Stockreport

AIM ImmunoTech Reminds Shareholders to Vote "FOR" All Four Incumbent Board Members on the WHITE Universal Proxy Card [Yahoo! Finance]

AIM ImmunoTech Inc.  (AIM) 
PDF Believes Incumbent Board is Best Positioned to Continue Overseeing the Clinical Development of Ampligen and Deliver Long-Term Value for All Shareholders Warns Shareho [Read more]